TRV-2026-1149Version 1 · Certified
Reason for this version
Certified into the record
Canonical text (the exact bytes fingerprinted)
TRUVACE RECORD VERSION record: TRV-2026-1149 version: 1 kind: certified reason: Certified into the record timestamp: 2026-09-20T06:53:32.779245Z status: published lens: p_space sector: health headline: Artificial Intelligence in Cerebral Small Vessel Disease Imaging: A Study-Level Cross-Sectional Analysis of Validation Status and Clinical Applicability dek: Artificial intelligence (AI) is increasingly used in cerebral small vessel disease (CSVD) imaging, but the extent of validation and clinical applicability across the literature remains uncertain. We performed a study-level cross-sectional analysis using a frozen Web of Science Core Collection (WoSCC) cohort supplemented by PubMed and IEEE Xplore searches to assess database coverage and the stability of findings from the WoSCC cohort. After study-level reconciliation, 463 independent studies were included. White… gain_title: (none) problem_title: Artificial Intelligence in Cerebral Small Vessel Disease Imaging: A Study-Level Cross-Sectional Analysis of Validation Status and Clinical Applicability: White matter hyperintensity segmentation/quantification was the most common task (196/463, 42.3%), followed by cerebral microbleed detection/classification (82/463, 17.7%), perivascular space/lacune assessment (67/463, 14.5%), CSVD burden/risk modeling (62/463, 13.4%), and clinical outcome prediction (56/463, 12.1%). trace_subject: (none) gain_reading: (none) gain_evidence: (none) problem_reading: Artificial Intelligence in Cerebral Small Vessel Disease Imaging: A Study-Level Cross-Sectional Analysis of Validation Status and Clinical Applicability: White matter hyperintensity segmentation/quantification was the most common task (196/463, 42.3%), followed by cerebral microbleed detection/classification (82/463, 17.7%), perivascular space/lacune assessment (67/463, 14.5%), CSVD burden/risk modeling (62/463, 13.4%), and clinical outcome prediction (56/463, 12.1%). problem_evidence: (none) quick_read: Artificial intelligence (AI) is increasingly used in cerebral small vessel disease (CSVD) imaging, but the extent of validation and clinical applicability across the literature remains uncertain. We performed a study-level cross-sectional analysis using a frozen Web of Science Core Collection (WoSCC) cohort supplemented by PubMed and IEEE Xplore searches to assess database coverage and the stability of findings from the WoSCC cohort. White matter hyperintensity segmentation/quantification was the most common task (196/463, 42.3%), followed by cerebral microbleed detection/classification (82/463, 17.7%), perivascular space/lacune assessment (67/463, 14.5%), CSVD burden/risk modeling (62/463, 13.4%), and clinical outcome prediction (56/463, 12.1%). Deep learning was the largest model family (185/463, 40.0%). limitation: tag: Evidence-backed problem key_points: Artificial intelligence (AI) is increasingly used in cerebral small vessel disease (CSVD) imaging, but the extent of validation and clinical applicability across the literature remains uncertain. | We performed a study-level cross-sectional analysis using a frozen Web of Science Core Collection (WoSCC) cohort supplemented by PubMed and IEEE Xplore searches to assess database coverage and the stability of findings from the WoSCC cohort. | After study-level reconciliation, 463 independent studies were included. rundown: Artificial intelligence (AI) is increasingly used in cerebral small vessel disease (CSVD) imaging, but the extent of validation and clinical applicability across the literature remains uncertain. We performed a study-level cross-sectional analysis using a frozen Web of Science Core Collection (WoSCC) cohort supplemented by PubMed and IEEE Xplore searches to assess database coverage and the stability of findings from the WoSCC cohort. After study-level reconciliation, 463 independent studies were included. White matter hyperintensity segmentation/quantification was the most common task (196/463, 42.3%), followed by cerebral microbleed detection/classification (82/463, 17.7%), perivascular space/lacune assessment (67/463, 14.5%), CSVD burden/risk modeling (62/463, 13.4%), and clinical outcome prediction (56/463, 12.1%). sources: - peer_reviewed | Journal of Imaging Informatics in Medicine | https://doi.org/10.1007/s10278-026-02327-x | 2026-09-18 prev: 0000000000000000000000000000000000000000000000000000000000000000
- sha256
- 2ef54cf6b6f30e4df3ad66c3fafc69a12e461c9ab28c4225f6ecf01140f7c4ed
- previous
- 0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1149 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace